Purpose of meeting
In a globalised healthcare ecosystem, supply chains become more complex, with an increased potential for quality issue to arise. So, it is critically important to understand Good Distribution Practices (GDP) and the requirements for shared responsibilities throughout the entire supply chain. This symposium will examine the regulatory requirements of GDP, provide an understanding of the issues and demonstrate how common problems can be overcome.
Challenge
"There is no such thing as a local firm, we are told; even the smallest shop in the remotest backwater is now part of the global supply chain. But, above all, it is inevitable." Schumpeter, The Economist, Aug 2012 (online)
So where does one even begin to ensure successful compliance with GDP?
Opportunities
- Application of science and technology to GDP
- Methods to evaluate the critical GDP risks
- System design and strategies to assure the quality of medicines
Proposed outcomes
You will leave this event with a clear understanding of the key regulations affecting the storage and distribution of medicines and the issues arising from interpretation and implementation. You will learn how industry is dealing with risk assessment, warehousing and distribution aspects, as well as investigational products, storage excursions and product security
In a globalised healthcare ecosystem, supply chains become more complex, with an increased potential for quality issue to arise. So, it is critically important to understand Good Distribution Practices (GDP) and the requirements for shared responsibilities throughout the entire supply chain. This symposium will examine the regulatory requirements of GDP, provide an understanding of the issues and demonstrate how common problems can be overcome.
Challenge
"There is no such thing as a local firm, we are told; even the smallest shop in the remotest backwater is now part of the global supply chain. But, above all, it is inevitable." Schumpeter, The Economist, Aug 2012 (online)
So where does one even begin to ensure successful compliance with GDP?
Opportunities
- Application of science and technology to GDP
- Methods to evaluate the critical GDP risks
- System design and strategies to assure the quality of medicines
Proposed outcomes
You will leave this event with a clear understanding of the key regulations affecting the storage and distribution of medicines and the issues arising from interpretation and implementation. You will learn how industry is dealing with risk assessment, warehousing and distribution aspects, as well as investigational products, storage excursions and product security
